Sanofi Wants FDA Approval Of Generic Lovenox Nixed
A federal judge heard Sanofi-Aventis U.S. LLC's bid Tuesday to force the U.S. Food and Drug Administration to withdraw its approval for a generic version of its anticoagulant Lovenox but didn't...To view the full article, register now.
Already a subscriber? Click here to view full article